Differentiated thyroid cancer is an infrequent disease with a generally good prognosis. The
initial treatment is total thyroidectomy coupled with ablation of thyroid remnants by iodine …

Simple Summary In the management of patients with differentiated thyroid cancer,
thyroglobulin (Tg) is used as a tumor marker to predict residual disease. After surgery, the …

Serum thyroglobulin (Tg) measurement is primarily used as a tumor marker to detect
recurrent or persistent disease in patients with differentiated thyroid carcinomas. It is …

Recombinant human TSH (rhTSH)-stimulated thyroglobulin (Tg) measurement and 131I
whole body scan (WBS) have been validated as informative tests in the postsurgical follow …

Serum thyroglobulin (Tg) is a suitable marker for differentiated thyroid carcinoma following
total thyroid ablation. Between 1998 and 2003, serum samples from 715 papillary and 179 …

Thyroglobulin is considered a reliable marker of recurrent disease in patients with well-
differentiated thyroid carcinoma. However, some patients present recurrence with no …

Objective A highly sensitive thyroglobulin assay (Elecsys® Tg II, Roche Diagnostics,
Penzberg, Germany) has become available for monitoring patients with differentiated thyroid …

We studied the potential role of innovative diagnostic tools for the management of patients
with differentiated thyroid cancer (DTC). Several methods for the detection of the tumor …

Background: Thyroglobulin is an excellent biological marker of persistent or recurrent thyroid
cancer during long-term follow-up. Most studies investigated its diagnostic value but not its …

Aim: To assess the impact of laboratory interferences and pitfalls in producing falsely
undetectable Tg in differentiated thyroid carcinoma (DTC) patients with residual iodine-avid …